Budesonide-formoterol reliever therapy versus maintenance . . . In adults with mild asthma, a combination of an inhaled corticosteroid with a fast-onset long-acting β-agonist (LABA) used as reliever monotherapy reduces severe exacerbations compared with short-acting β-agonist (SABA) reliever therapy
Asthma control with ICS-formoterol reliever versus . . . To assess the levels and changes in asthma control for as-needed budesonide–formoterol versus maintenance budesonide plus SABA in post hoc analyses from the Novel START and PRACTICAL clinical trials
Novel START - Wiki Journal Club The 2019 Novel START trial randomized 675 adults with mild asthma to 1 of 3 arms in an open-label fashion: 1 Budesonide+formoterol PRN (ICS+LABA PRN), 2 Albuterol PRN (SABA PRN), or 3
63. Rapid Fire Journal Club 5 – Novel START | PulmPEEPs Today on our Rapid Fire Journal Club series, we’re discussing the Novel START study published in the NEJM in 2019 This study evaluated multiple strategies for the management of mild asthma with exacerbations, and it guides our current therapeutic approach Pulm PEEPs Associate Editor Luke Hedrick walks us through the study
Controlled Trial of Budesonide-Formoterol as Needed for Mild . . . In an open-label trial involving adults with mild asthma, budesonide-formoterol used as needed was superior to albuterol used as needed for the prevention of asthma exacerbations (Funded by AstraZeneca and the Health Research Council of New Zealand; Novel START Australian New Zealand Clinical Trial …